Skip to Content

Join the 'Trexall' group to help and get support from people like you.

Trexall News

Severe Psoriasis May Make Diabetes Increasingly Likely

Posted 1 day 1 hour ago by Drugs.com

MONDAY, Nov. 20, 2017 – People with the skin disease psoriasis are at increased risk for type 2 diabetes, and the more severe the psoriasis, the greater their risk, a new study finds. Researchers examined data on nearly 85,000 adults in the United Kingdom, including 8,100 who had psoriasis. Compared with people who did not have psoriasis, the risk for diabetes was 21 percent higher among those with psoriasis on 2 percent or less of their body. It was 64 percent higher among those with psoriasis on more than 10 percent of their body. For every 10 percent increase in body area with psoriasis, the risk for diabetes rose another 20 percent. For instance, people with psoriasis on 20 percent of their body had a nearly 84 percent increased risk for diabetes. And those with psoriasis on 30 percent of their body had a 104 percent increased risk, the study authors said. When applying their ... Read more

Related support groups: Diabetes, Type 2, Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Resorcinol, Enstilar, Vectical, Oxsoralen, Anthralin, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Methoxsalen, Tazarotene

Do Rising Cancer Drug Prices Warrant Regulation?

Posted 1 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 1, 2017 – Cancer drug prices in the United States keep rising steadily, a new study says. "Regardless of competition or supplemental indications, our study found that there is a steady increase in costs of patented anticancer drugs over time," wrote the researchers. They included Dan Greenberg, an associate professor at Ben-Gurion University of the Negev in Israel. "We believe that new regulations may be needed to prevent additional increases in drug costs after launch, especially since Medicare is legally prohibited from negotiating drug prices," the researchers said in a university news release. Greenberg and his research team from Israel and the United States monitored monthly prices of 24 injectable, patented cancer drugs approved by the U.S. Food and Drug Administration between 1996 and 2012. Prices were tracked for eight years on average. After adjusting for ... Read more

Related support groups: Cancer, Methotrexate, Fluorouracil, Gleevec, Colorectal Cancer, Xeloda, Tasigna, Sprycel, Herceptin, Hydroxyurea, Erivedge, Mercaptopurine, Hydrea, Cisplatin, Carboplatin, Cytoxan, Bendamustine, Capecitabine, Temodar, Cyclophosphamide

Speed Up the 'Cancer Moonshot,' Doctors Urge

Posted 1 Nov 2017 by Drugs.com

TUESDAY, Oct. 31, 2017 – The Cancer Moonshot Initiative now has a detailed road map designed to cram a decade's worth of medical advancement into half that time. A new report, authored by more than 50 leading U.S. cancer doctors, highlights 13 priority areas for improving the medical response to cancer, along with measurable goals and a specific timeline for meeting each of those objectives. The plan is intended to help "accelerate existing progress so that we deliver in five years what would have historically taken 10," said Dr. Cliff Hudis, chief executive officer of the American Society of Clinical Oncology and co-author of the report. It was created by The Lancet Oncology Commission on Future Research Priorities in the USA. In late 2016, Congress appropriated $1.8 billion for cancer research funding over the next seven years for the so-called Cancer Moonshot, said commission ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Xeloda, Tasigna, Sprycel, Herceptin, Hydroxyurea, Mercaptopurine, Cervical Cancer, Hydrea, Cisplatin, Carboplatin

Cyndi Lauper's Psoriasis Battle Shows Her 'True Colors'

Posted 25 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 25, 2017 – With her pink tresses and eye-catching stage costumes, pop culture icon Cyndi Lauper was never one to hide. But that's exactly what she wanted to do when she developed psoriasis, which spread to most of her body and sapped her strength before the skin disorder was controlled. Appearing first on her scalp and later covering everything except her face, psoriasis struck Lauper in 2010 while the Grammy, Tony and Emmy award-winning singer-songwriter – famous for 1980s' hits such as "Girls Just Want to Have Fun" and "Time After Time" – was on tour. She soldiered through appearances despite crushing exhaustion and an inability to regulate her temperature, which left her zigzagging between hot and cold. "It's funny – you start wearing gloves, or this and that, hoping that [psoriasis] is invisible, but it's not. I wasn't wearing it like, 'Woo-hoo, check this out!' ... Read more

Related support groups: Skin Rash, Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Resorcinol, Enstilar, Vectical, Oxsoralen, Anthralin, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Methoxsalen, Tazarotene

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps to reduce health costs. To save money, nearly one in 10 said they had avoided doctor appointments. Eight percent had refused treatment; postponed filling or not filled prescriptions; or skipped doses of prescribed medications. And 7 percent said they had cut pills in half, according to the survey of more than 4,000 adults. Such measures can jeopardize treatment success, ASCO says. "We should all be alarmed that Americans are potentially risking not only their health, but also their lives, due to ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Votrient, Letrozole, Tarceva

Arthritis Can Strike Children

Posted 18 Oct 2017 by Drugs.com

TUESDAY, Oct. 17, 2017 – While arthritis is typically thought of as an older person's disease, more than 300,000 American children have chronic juvenile idiopathic arthritis (JIA), an expert says. Unlike age-related arthritis caused by cartilage and bone wear and tear, JIA has more to do with joint inflammation, but it's not clear what triggers this inflammation, said Dr. Barbara Ostrov, a pediatric and adult rheumatologist at Penn State Health in Hershey, Pa. Symptoms of JIA include joints that are consistently swollen, stiff or inflamed. In some cases, the disease also affects the eyes and can threaten vision if not diagnosed and treated promptly. All children with JIA should be monitored by an ophthalmologist. The youngest children with JIA often don't complain about their pain. Signs that they may have JIA include wanting to be carried for the first couple of hours a day due to ... Read more

Related support groups: Rheumatoid Arthritis, Methotrexate, Juvenile Rheumatoid Arthritis, Methotrexate LPF Sodium, Folex PFS, Xatmep, Rheumatrex Dose Pack, Rasuvo, Trexall, Otrexup

Cancer Treatment Can Affect Your Food Preferences

Posted 19 Sep 2017 by Drugs.com

TUESDAY, Sept. 19, 2017 – Cancer therapies often change patients' sense of taste, which may affect what they like to eat, according to a nutrition expert. "Increased taste sensitivities are more common than a muting of taste," said Catherine Carpenter, professor of clinical nutrition at UCLA's David Geffen School of Medicine. "Usually, the type of taste sensitivity encountered is one of a metallic nature." Changes in tastes often influence a person's food preferences, but treatment may affect individuals differently, Carpenter noted in a university news release. "If anything, patients tend to prefer bland foods rather than spicy foods," she said. "It's important to remember that preferences may vary depending on the cancer and type of treatment. You cannot lump all cancer patients into one dietary regimen." After treatments, such as chemo or radiation therapy, a nutritionist can help ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Xerostomia, Oral and Dental Conditions, Fluorouracil, Colorectal Cancer, Xeloda, Hydroxyurea, Nausea/Vomiting - Chemotherapy Induced, Mercaptopurine, Hydrea, Capecitabine, Gemzar, Dacogen, Gemcitabine, Cytarabine, Cladribine, Decitabine, Purinethol

Severe Psoriasis Linked to Higher Risk of Earlier Death

Posted 5 Sep 2017 by Drugs.com

TUESDAY, Sept. 5, 2017 – People with severe cases of the skin disease psoriasis appeared to have almost double the risk of dying during a four-year study than people without the condition, research suggests. But the increased death rate was only seen in those with psoriasis affecting more than 10 percent of their body surface area. For those with less-severe disease, the risk of dying early was actually less than it was for people who didn't have the skin condition. Dr. Robert Kirsner, chair of dermatology at the University of Miami Miller School of Medicine, said that over the last decade or so, doctors have learned that people with psoriasis tend to be less healthy. "They are overweight, have diabetes mellitus, smoke, drink and have high cholesterol," he said. "These factors – as well as the presence of psoriasis itself – increases their risk for vascular disease and other poor ... Read more

Related support groups: Skin Rash, Smoking, Methotrexate, Psoriasis, Smoking Cessation, Plaque Psoriasis, Diabetes Mellitus, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Vectical, Enstilar, Anthralin, Oxsoralen, Resorcinol, Oxsoralen-Ultra, Methoxsalen

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. "It is our hope that this information can be used by patients and physicians when discussing the impact of cancer treatment decisions on survival," Johnson said in a school news release. Steve Jobs, co-founder and former CEO of Apple, is likely the most famous person who initially chose alternative medicine as a sole treatment. He eventually turned back to conventional medicine when the alternative medicine treatment didn't keep his pancreatic cancer at bay. But at that point, the cancer had ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Anastrozole, Letrozole, Xeloda, Megestrol, Zoladex, Megace, Evista, Pancreatic Cancer, Hydroxyurea

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Prostate Cancer, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Anastrozole, Brain Tumor, Votrient, Letrozole

Childhood Chemo May Have Lasting Effects on Memory

Posted 20 Jun 2017 by Drugs.com

TUESDAY, June 20, 2017 – Childhood cancer survivors who had chemotherapy may have certain types of thinking and memory problems as young adults, a small study suggests. Belgian researchers assessed 31 young adults who had undergone chemotherapy. They were at an average age of slightly over 6 when they had the treatment. The researchers compared them with a control group of young adults who hadn't received chemotherapy. Both groups had similar scores on tests of long-term memory and ability to concentrate. Those are skills that developed before the cancer survivors underwent chemotherapy, the researchers said. But compared to the control group, the cancer survivors had poorer thinking flexibility and short-term memory. These skills develop at a later age, the researchers explained. "Tests that require quick switching between tasks or remembering new information for a short amount of ... Read more

Related support groups: Cancer, Methotrexate, Fluorouracil, Leukemia, Xeloda, Hydroxyurea, Mercaptopurine, Hydrea, Cisplatin, Carboplatin, Bendamustine, Cytoxan, Capecitabine, Temodar, Cyclophosphamide, Gemzar, Oxaliplatin, Dacogen, Gemcitabine, Treanda

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, the clinical trials studied extended life by 3.34 million years, the study found. SWOG estimates the dollar return on investment from federal funding at $125 for each year of life gained. "A lot of people with cancer have lived longer because of the therapies tested in our publicly funded trials," study leader Joseph Unger said in a SWOG news release. He is an assistant member of the Fred Hutchinson Cancer Research Center's Cancer Prevention Program in Seattle. "At the same time, the cost of ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Rituxan, Isotretinoin, Colorectal Cancer

Early Treatment Equals Better Results for Rheumatoid Arthritis

Posted 25 Apr 2017 by Drugs.com

TUESDAY, April 25, 2017 – Treating rheumatoid arthritis early may make for better outcomes, a new study suggests. Patients who were treated within six months of developing the first signs of the autoimmune disease did better in the long run and were less likely to suffer early death, British researchers found. The findings stem from an analysis of more than 600 patients who were initially diagnosed with rheumatoid arthritis (RA) between 1990 and 1994. They were tracked for over 20 years. Over the study time frame, investigators assessed key symptoms of RA, such as swollen and/or tender joints, and indications of disability. All deaths were also noted. The research team found that patients who started treatment for RA within the first half-year after the first symptoms surfaced tended to have no greater levels of disability over a 20-year period than patients who required no treatment. ... Read more

Related support groups: Rheumatoid Arthritis, Methotrexate, Humira, Enbrel, Remicade, Plaquenil, Hydroxychloroquine, Rituxan, Otezla, Imuran, Sulfasalazine, Orencia, Rituximab, Arava, Leflunomide, Juvenile Rheumatoid Arthritis, Azathioprine, Xeljanz, Juvenile Idiopathic Arthritis, Infliximab

Siliq Approved for Plaque Psoriasis

Posted 2 Mar 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults. Siliq is approved for patients who've already failed to respond to other systemic therapies, the agency noted. The autoimmune disease – so-called because the immune system produces antibodies that attack the body's own tissues – causes thick, scaly patches of red skin. The drug is designed to inhibit the body's inflammatory response that plays a role in the development of plaque psoriasis, the FDA said in a news release. The disease occurs most often in people with a family history, usually between ages 15 and 35. Saliq was evaluated in clinical studies involving more than 4,300 people with moderate-to-severe plaque psoriasis. The most common side effects included joint pain, headache, fatigue, diarrhea, ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Anthralin, Resorcinol, Oxsoralen, Enstilar, Vectical, Methoxsalen, Tazarotene, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Psoriatec

FDA Approves Injectable Psoriasis Drug Siliq for Tough Cases

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – A new drug to treat tough cases of the skin condition psoriasis has won approval from the U.S. Food and Drug Administration. Valeant Pharmaceuticals' injectable drug Siliq (brodalumab) was approved for adults with moderate-to-severe psoriasis that isn't responding to other recommended treatments. However, the drug carries a warning about increased risk for suicidal behavior. Psoriasis is characterized by raised patches of red skin and flaking. The condition usually begins between ages 15 and 35 and is thought to be an autoimmune disorder, meaning the body mistakenly attacks healthy cells. "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today's approval provides patients with another treatment option for their psoriasis," said the FDA's Dr. Julie Beitz. Beitz is director of the Office of Drug ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Anthralin, Resorcinol, Oxsoralen, Enstilar, Vectical, Methoxsalen, Tazarotene, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Psoriatec

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia, Dermatomyositis, Systemic Sclerosis, Acute Lymphocytic Leukemia, Neoplastic Diseases, view more... Choriocarcinoma, Mycosis Fungoides, Meningeal Leukemia, Lymphoma, Non-Small Cell Lung Cancer, Osteosarcoma, Head and Neck Cancer, Graft-versus-host disease, Solid Tumors, Breast Cancer, Trophoblastic Disease

Trexall Patient Information at Drugs.com